Efficacy and Safety of Paromomycin for Visceral Leishmaniasis: A Systematic Review
Visceral leishmaniasis, also known as kala-azar is one of the most commonly neglected tropical diseases affecting a large number of rural and resource-limited people in South Asia, Africa, and South America. Paromomycin, an aminoglycoside drug, is frequently used for the treatment of visceral leishm...
Saved in:
Main Authors: | Pashupati Pokharel, Rakesh Ghimire, Pratik Lamichhane |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Journal of Tropical Medicine |
Online Access: | http://dx.doi.org/10.1155/2021/8629039 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phase 4 Pharmacovigilance Trial of Paromomycin Injection for the Treatment of Visceral Leishmaniasis in India
by: Prabhat K. Sinha, et al.
Published: (2011-01-01) -
Efficacy of vaccines based on chimeric or multiepitope antigens for protection against visceral leishmaniasis: A systematic review.
by: Karine Ferreira Lopes, et al.
Published: (2024-12-01) -
Immunity to Visceral Leishmaniasis
by: Nahid Ali, et al.
Published: (2012-01-01) -
Visceral Leishmaniasis or Systemic Lupus Erythematosus Flare?
by: Sunny Garg, et al.
Published: (2012-01-01) -
Modeling and analyzing the transmission dynamics of visceral leishmaniasis
by: Lan Zou, et al.
Published: (2017-09-01)